23 November 2018 - The Global Minoxidil
Market is slated to post high growth in the forthcoming period. Minoxidil
is a drug used for treatment of hair loss in individuals and it is available as
a generic prescription drug OTC. Minoxidil is an antihypertensive vasodilator
medication and treats androgenic alopecia specifically. Minoxidil targets small
blood vessels and develops key cell instincts for hair growth that comprise the
main factors for hair regrowth by attractive hair growth formulation called
minoxidil. Minoxidil is a hair stimulant and works best when hair balding is in
initial stages and stops hair loss or alopecia immediately.
The
popularity of minoxidil can be gauged by its success rate and that is men
experience hair regrowth after 3-6 months on one condition that the hair should
be treated constantly with minoxidil for the hair to experience improvement in
hair’swell-being. This can be termed as growth factors for minoxidil. Minoxidil
is generally well tolerated in people of all ages.
Restraints
to minoxidil are common side effects such as burning or redness of eye,
itching, difficulty in breathing and tightness in the chest, tachycardia and
unexplained weight gain. A common side-effect observed is hair fall during
medication that is quite customary with minoxidil.
Some
further side-effects that come to the eye include swelling of face and
extremities, rapid and irregular heartbeat, lightheadedness and some allergic
reactions. Androgenic alopecia is the main cause of hair loss worldwide, both
among men and women and they are linked to coronary heart disease, different
types of cancer and diabetes. Minoxidil has renowned properties for making hair
stay in place by acting on hair follicles in angen phase- root of hair growth.
Minoxidil is known to increase blood supply in hair follicles and hence has
been verified for good hair growth.
Minoxidil
medication is more noticeable on crown of the head where hair growth is more
visible and thins out towards hairline and frontal area. Minoxidil works as
naturally as it can with results seen from month four onwards and hair grows
1mm each day thus contradicting any notions that minoxidil is a miracle cure.
Segmentation
of minoxidil market by application includes alopecia, hair loss treatment, hair
replacement surgery and chemotherapy. By geographical region, segmentation of
minoxidil market includes North America, Europe, Asia pacific, MEA and Latin
America. The key industrial players in minoxidil market include McNeil Consumer
Healthcare, Changland Technology, Proderma SRL, Pharone International, Meta
Pharmaceutical Ind., Suzohou Harborbiotech, Carnosine, Darkar Holdings, and lOy
Pharma Lab.
Market Segment:
Geographically, this report is segmented
into several key Regions, with production, consumption, revenue (million USD),
market share and growth rate of Minoxidil in these regions, from 2013 to 2025
(forecast), covering
•
North America
•
Europe
•
China
•
Japan
•
Southeast Asia
•
India
Global Minoxidil market competition by
top manufacturers, with production, price, revenue (value) and market share for
each manufacturer; the top players including
•
J&J
•
Taisho Pharma
•
Costco Wholesale
•
Wal-Mart
•
P&G
•
Zhejiang Wansheng Pharma
•
Sichuan Medco Huakang Pharma
•
Zhendong Anter
Comments
Post a Comment